Found 21 hits with Last Name = 'garay' and Initial = 'rp' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
5-hydroxytryptamine receptor 2A
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Rattus norvegicus (Rat)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
D(3) dopamine receptor
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
D(1A) dopamine receptor
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 3.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
D(4) dopamine receptor
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 5.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 5.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Histamine H1 receptor
(Cavia porcellus (domestic guinea pig)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 9.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 2C
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M4
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M1
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 7
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M3
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M5
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Muscarinic acetylcholine receptor M2
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 3A
(Mus musculus (house mouse)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Histamine H2 receptor
(Cavia porcellus (domestic guinea pig)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 351 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Alpha-2C adrenergic receptor
(RAT) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.32E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
5-hydroxytryptamine receptor 3A
(Homo sapiens (Human)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Hrh3 protein
(RAT) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | KEGG
UniProtKB/TrEMBL
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Gamma-aminobutyric acid type B receptor subunit 1
(Rattus norvegicus (Rat)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |
Gamma-aminobutyric acid receptor subunit alpha-1
(Rattus norvegicus (Rat)) | BDBM86057
(CAS_62865 | Cyamemazine | NSC_62865)Show InChI InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma
Curated by PDSP Ki Database
| |
Biochem Pharmacol 65: 435-40 (2003)
Article DOI: 10.1016/s0006-2952(02)01515-0 BindingDB Entry DOI: 10.7270/Q2Q81BMG |
More data for this Ligand-Target Pair | |